Lloyd E. Johnson - 31 Mar 2026 Form 4 Insider Report for APOGEE ENTERPRISES, INC. (APOG)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
01 Apr 2026, 17:13:47 UTC
Prior SEC filing
06 Jan 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/David Wright Walstrom, Attorney-in-Fact for Lloyd E. Johnson

Key filing fact

Lloyd E. Johnson filed Form 4 for APOGEE ENTERPRISES, INC. (APOG) on 01 Apr 2026.

Key facts

  • This page summarizes Lloyd E. Johnson's Form 4 filing for APOGEE ENTERPRISES, INC. (APOG).
  • 1 reported transaction and 1 derivative row are listed below.
  • Accepted by SEC: 01 Apr 2026, 17:13.

Change

  • Previous filing in this sequence was filed on 06 Jan 2026.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001708823 Primary reporting owner

Johnson Lloyd Emerson

Relationship
Director
Address
C/O APOGEE ENTERPRISES, INC., 4400 WEST 78TH STREET, SUITE 520, MINNEAPOLIS
Signature
/s/David Wright Walstrom, Attorney-in-Fact for Lloyd E. Johnson
Signature date
01 Apr 2026

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

APOG transaction Derivative

Deferred Restricted Stock Units

Award

Transaction value
Shares
+153
Change %
+0.8%
Price
$33.54*
Shares after
19,264
Date
31 Mar 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
153
Exercise price
Footnotes
F1, F2, F3
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

Settled 1-for-1.

Footnote F2

Additional deferred restricted stock units acquired pursuant to a dividend equivalent reinvestment feature of the 2009 Non-Employee Director Stock Incentive Plan and the 2019 Non-Employee Director Stock Plan.

Footnote F3

The deferred restricted stock units were allocated under the 2009 Non-Employee Director Stock Incentive Plan and the 2019 Non-Employee Director Stock Plan. The deferred restricted stock units will be settled in shares of common stock following the director's termination from the Board in accordance with the election of the reporting person, or following the occurrence of other events specified in the Plan.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .